Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit

The merger of Pfizer's (NYSE:PFE) generic drug business, Upjohn, with Mylan (NASDAQ:MYL) will be going through shortly, now that the companies have agreed to a consent order with the U.S. Federal Trade Commission. The companies didn't give any details about what they had agreed to do in order to comply with that consent order.